1. What is the true incidence of CCSVI in patients with MS in a study comparing MRI on MS
patients and controls.
2. Are the beneficial outcomes from treatment placebo? By measuring changes in brain
perfusion and Cerebrospinal flow before and after the procedure on a large number of
patients to determine these outcomes